Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.74 |
| ▸ | CA1 | P00915 | 15/20 | 0.72 |
| ▸ | CA2 | P00918 | 15/20 | 0.72 |
| ▸ | CA9 | Q16790 | 9/20 | 0.70 |
| ▸ | CA12 | O43570 | 7/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | CA7 | P43166 | 3/20 | 0.68 |
| ▸ | CA4 | P22748 | 2/20 | 0.68 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | CA5A | P35218 | 1/20 | 0.62 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17510035 | 0.86 | CA1 (0.77) | CA1CA2CA9CA12KMT2A | |
| SCHEMBL10996832 | 0.85 | PRMT1 (1.00) | PRMT1CA1CA2CA9CA12 | |
| SCHEMBL8047403 | 0.84 | PRMT1 (0.77) | PRMT1CA1CA2CA9CA12 | |
| SCHEMBL14155782 | 0.84 | PRMT1 (0.77) | PRMT1CA1CA2CA9CA12 | |
| SCHEMBL9780028 | 0.84 | CA1 (1.00) | CA1CA2CA9CA12KMT2A | |
| SCHEMBL9081388 | 0.82 | NPC1 (0.76) | PRMT1KMT2AMEN1MAPT | |
| SCHEMBL23388362 | 0.82 | CA1 (0.72) | CA1CA2CA9CA12KMT2A | |
| Potassium Ion SCHEMBL11518837 | 0.82 | PRMT1 (0.74) | PRMT1CA1CA2CA9CA12 | |
| SCHEMBL5806411 | 0.82 | CA1 (0.76) | CA1CA2CA9CA12KMT2A | |
| SCHEMBL13263684 | 0.82 | CA1 (1.00) | CA1CA2CA9CA12KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529345-A | Antibacterial cellulose modified polylactic acid and preparation method thereof | 长春市快快网络科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| WO-2022055467-A1 | CERTAIN NEW 4-(2-((5-(SUBSTITUTEDAMINO)-1,3,4-THIADIAZOLE-2-YL)THIO)ACETYL)BENZENESULPHONEAMIDE DERIVATIVES AND A METHOD FOR THE SYNTHESIS OF SAID DERIVATIVES | Anadolu Üniversitesi (TR) | 2022-03-17 | — | — | WO | claimed |
| US-9598361-B1 | Amino substituted acetamide derivative | KING SAUD UNIVERSITY (SA) | 2017-03-21 | — | — | US | claimed |
| EP-2987533-A1 | 7-substituted piperazin-1-yl fluoroquinolone compounds, their use in the treatment of cancer, pharmaceutical compositions and a method for preparation | King Saud University (SA) | 2016-02-24 | — | — | EP | claimed |
| CN-119529345-A | Antibacterial cellulose modified polylactic acid and preparation method thereof | 长春市快快网络科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12139461-B1 | Piperidine compounds as PDE5 inhibitors | KING SAUD UNIVERSITY (SA) | 2024-11-12 | — | — | US | disclosed |
| CN-116987032-A | 4-piperazine amide benzenesulfonamide-1, 8-naphthalimide derivative, and preparation method and application thereof | 桂林医学院 | 2023-11-03 | — | — | CN | disclosed |
| WO-2022055467-A1 | CERTAIN NEW 4-(2-((5-(SUBSTITUTEDAMINO)-1,3,4-THIADIAZOLE-2-YL)THIO)ACETYL)BENZENESULPHONEAMIDE DERIVATIVES AND A METHOD FOR THE SYNTHESIS OF SAID DERIVATIVES | Anadolu Üniversitesi (TR) | 2022-03-17 | — | — | WO | disclosed |
| CN-107922345-B | Arylsulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use | 圣诺康生命科学公司 | 2021-03-23 | — | — | CN | disclosed |
| US-10562859-B2 | Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use | SIGNALCHEM LIFESCIENCES CORPORATION (CA) | 2020-02-18 | — | — | US | disclosed |
| US-10562859-B2 | Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use | SIGNALCHEM LIFESCIENCES CORPORATION (CA) | 2020-02-18 | — | — | US | disclosed |
| US-20180201584-A1 | ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE | SIGNALCHEM LIFESCIENCES CORPORATION (CA) | 2018-07-19 | — | — | US | disclosed |
| US-9598361-B1 | Amino substituted acetamide derivative | KING SAUD UNIVERSITY (SA) | 2017-03-21 | — | — | US | disclosed |
| US-9598361-B1 | Amino substituted acetamide derivative | KING SAUD UNIVERSITY (SA) | 2017-03-21 | — | — | US | disclosed |
| US-9598361-B1 | Amino substituted acetamide derivative | KING SAUD UNIVERSITY (SA) | 2017-03-21 | — | — | US | disclosed |
| WO-2017004543-A1 | ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE | SIGNALCHEM LIFESCIENCES CORPORATION (CA) | 2017-01-05 | — | — | WO | disclosed |
| EP-2987533-A1 | 7-substituted piperazin-1-yl fluoroquinolone compounds, their use in the treatment of cancer, pharmaceutical compositions and a method for preparation | King Saud University (SA) | 2016-02-24 | — | — | EP | disclosed |
| US-8933267-B2 | Compounds for use as anti-ulcer agent and/or anti-Helicobacter pylori agent and pharmaceutical compositions thereof | KING SAUD UNIVERSITY (SA) | 2015-01-13 | — | — | US | disclosed |
| US-20140329778-A1 | COMPOUNDS FOR USE AS ANTI-ULCER AGENT AND/OR ANTI-HELICOBACTER PYLORI AGENT AND PHARMACEUTICAL COMPOSITIONS THEREOF | KING SAUD UNIVERSITY (SA) | 2014-11-06 | — | — | US | disclosed |
| US-4499100-A | CARDIOUVASCULAR DISORDERS | SYNTEX (U.S.A.) INC. (US) | 1985-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10562859-B2 | Aryl sulfonamide compounds as carbonic anhydrase inhibitors and their therapeutic use | CA9, CA4, CA7 | PRMT1 4040/4885CA1 8/4885CA2 5/4885 |
| US-20180201584-A1 | ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE | CA9, CA4, CA7 | PRMT1 4040/4885CA1 8/4885CA2 5/4885 |
| US-12139461-B1 | Piperidine compounds as PDE5 inhibitors | PDE5A, PDE3A, PDE2A | PRMT1 193/4885CA1 4783/4885CA2 3683/4885 |
| US-20140329778-A1 | COMPOUNDS FOR USE AS ANTI-ULCER AGENT AND/OR ANTI-HELICOBACTER PYLORI AGENT AND PHARMACEUTICAL COMPOSITIONS THEREOF | HRH2, HRH1, HRH4 | PRMT1 3518/4885CA1 3886/4885CA2 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.